YOLFTbeta
China Resources Medical Holdings Company Limited

China Resources Medical Holdings Company Limited

1PH · F · Healthcare / Medical Care Facilities

0.276EUR-0.01 (-2.13%)

Price History

Full chart

Market Stats

Previous Close0.282
Open0.276
Day Range0.276 – 0.276
52-Week Range0.2461 – 0.3757
Volume0
Market Cap333.82M
P/E (TTM)6.60
Forward P/E16.21
EPS0.04
Dividend Yield6.36%
Beta0.57
50-Day Avg0.2752
200-Day Avg0.3002

About

China Resources Medical Holdings Company Limited, an investment holding company, provides general healthcare, hospital management, and other hospital-related services in the People's Republic of China. It operates through two segments Hospital and Other Business. The Hospital segment offers out-patient and in-patient business corresponding to self-owned hospitals. The Other Business segment offers operation management services, supply chain services, and other services to participating hospitals and IOT/OT hospitals. The company manages and operates third-party hospitals and clinics under the IOT model. In addition, it sells pharmaceuticals, medical devices, medical consumables, and non-medical supply. The company was formerly known as China Resources Phoenix Healthcare Holdings Company Limited and changed its name to China Resources Medical Holdings Company Limited in October 2018. The company was founded in 2007 and is headquartered in Beijing, the People's Republic of China.

Company Details

  • SectorHealthcare
  • IndustryMedical Care Facilities
  • CEOMr. Chuang Zhang
  • Employees19.18K
  • HeadquartersKunlun Center Office Building, Beijing, China, 100069, Germany
  • Websitehttps://www.crmedical.hk

Leadership

  • Mr. Hai YuChairman · b. 1968
  • Mr. Chuang ZhangCEO & Executive Director · b. 1978
  • Mr. Xinchun WuExecutive Director & VP · b. 1971
  • Mr. Changjiu YuChief Financial Officer · b. 1980
  • Mr. Yuexing WangExecutive Director · b. 1972
  • Mr. Bing ZhangVice President · b. 1972
  • Mr. Dayi GongVice President · b. 1977

Financials

Income Statement

Currency: CNY2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.53B1.88B2.06B2.12B2.75B4.45B5.62B10.11B9.85B9.18B
Growth (%)-+22.50%+9.68%+2.71%+30.03%+61.69%+26.37%+79.83%-2.50%-6.89%
Cost of Revenue1.13B1.21B1.30B1.35B2.11B3.51B4.65B8.20B8.04B7.73B
Gross Profit406.63M668.24M756.68M762.29M636.51M933.55M971.14M1.91B1.81B1.44B
Gross Margin26.53%35.59%36.74%36.04%23.14%20.99%17.28%18.86%18.36%15.70%
Operating Expense172.02M211.62M223.43M253.57M334.19M485.29M636.77M943.05M1.03B978.60M
Operating Income234.61M456.61M533.25M508.72M302.31M448.26M334.37M962.78M774.98M462.18M
Operating Margin15.31%24.32%25.89%24.05%10.99%10.08%5.95%9.53%7.86%5.04%
EBITDA-628.71M668.73M620.50M548.59M469.59M621.13M1.22B1.52B1.36B
EBITDA Margin-33.48%32.47%29.33%19.94%10.56%11.05%12.06%15.41%14.87%
Net Income-1.51B421.03M430.90M390.87M310.13M417.92M138.97M257.68M565.88M495.94M
Net Income Margin-98.31%22.42%20.92%18.48%11.27%9.40%2.47%2.55%5.74%5.41%
Interest Expense007.70M16.43M17.02M16.23M46.23M114.86M61.01M31.95M
Interest Expense % of Total Revenue0.00%0.00%0.37%0.78%0.62%0.37%0.82%1.14%0.62%0.35%

Balance Sheet

Currency: CNY2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets6.45B6.91B7.32B7.87B8.96B10.47B11.10B13.65B13.32B12.91B
Total Liabilities1.09B1.31B1.61B1.73B2.62B3.62B4.11B6.64B5.82B5.03B
Total Equity5.24B5.48B5.59B5.90B6.11B6.45B6.46B5.81B6.21B6.55B
Cash1.07B877.05M1.52B2.01B2.70B2.32B2.98B1.28B977.33M939.62M
Net Debt-------882.34M459.08M-

Cash Flow

Currency: CNY2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow223.79M459.54M334.15M366.05M643.69M710.43M626.58M1.20B1.27B1.36B
Investing Cash Flow120.41M-545.08M355.42M157.24M60.37M-1.94B----
Financing Cash Flow--104.07M-44.72M-40.97M-7.38M845.96M----
Capital Expenditure42.45M34.50M57.61M36.37M209.55M198.43M252.87M486.68M563.69M514.13M
Free Cash Flow-425.04M276.54M329.69M426.14M483.17M373.72M708.44M706.57M844.41M
Dividends Paid83.11M69.93M118.57M131.49M115.09M91.08M129.60M42.35M139.13M166.89M
FCF to OCF-92.49%82.76%90.07%66.20%68.01%59.64%59.28%55.62%62.16%
Dividend Paid to FCF-16.45%42.87%39.88%27.01%18.85%34.68%5.98%19.69%19.76%

Earnings

Report DateMar 23, 2027
EPS Estimate-
EPS Actual-
Surprise-
TimingAfter-hours

Key Statistics & Ratios

Market Cap333.82M
Enterprise Value315.98M
Trailing P/E6.60
Forward P/E16.21
Price / Sales0.04
Price / Book0.38
EPS0.04
Book Value0.6896
Revenue (TTM)9.13B
Gross Profit (TTM)1.55B
EBITDA1.06B
Profit Margin4.62%
Operating Margin7.64%
Return on Equity6.32%
Return on Assets2.52%
Shares Outstanding1.26B
Shares Float822.14M
Beta0.57
Dividend Yield6.36%
Dividend Rate0.02
Payout Ratio40.56%

Dividends

20262×
0.01Sep 11, 20260.01Jun 30, 2026
20252×
0.01Sep 10, 20250.01Jun 9, 2025
20242×
0.01Sep 9, 20240.01Jun 7, 2024
20231×
0.00Jun 7, 2023
20221×
0.01Jun 7, 2022
20211×
0.01Jun 7, 2021
20201×
0.01Jun 1, 2020
20191×
0.01Jul 11, 2019
20181×
0.01Jun 12, 2018
20171×
0.01Jun 21, 2017
20162×
0.01Jun 14, 20160.01Jan 7, 2016
20151×
0.01Jun 8, 2015
20141×
0.01Jun 10, 2014